Literature DB >> 29307847

Yield of Higher-Grade Neoplasia in Barrett's Esophagus With Low-Grade Dysplasia Is Double in the First Year Following Diagnosis.

Joel H Rubenstein1, Akbar K Waljee2, Ben Dwamena3, Jacques Bergman4, Michael Vieth5, Sachin Wani6.   

Abstract

Entities:  

Mesh：

Year:  2018        PMID： 29307847      PMCID： PMC6030504          DOI： 10.1016/j.cgh.2018.01.002

Source DB:  PubMed          Journal:  Clin Gastroenterol Hepatol        ISSN： 1542-3565            Impact factor:   11.382


× No keyword cloud information.
  8 in total

1.  Trends in Barrett's esophagus diagnosis in Southern Europe: implications for surveillance.

Authors:  Javier Alcedo; Angel Ferrández; Juan Arenas; Federico Sopeña; Javier Ortego; Ricardo Sainz; Angel Lanas
Journal:  Dis Esophagus       Date:  2009       Impact factor: 3.429

2.  Routinely diagnosed low-grade dysplasia in Barrett's oesophagus: a population-based study of natural history.

Authors:  Piers Gatenby; James Ramus; Christine Caygill; Neil Shepherd; Marc Winslet; Anthony Watson
Journal:  Histopathology       Date:  2009-06       Impact factor: 5.087

3.  The diagnosis of low-grade dysplasia in Barrett's esophagus and its implications for disease progression.

Authors:  M Skacel; R E Petras; T L Gramlich; J E Sigel; J E Richter; J R Goldblum
Journal:  Am J Gastroenterol       Date:  2000-12       Impact factor: 10.864

4.  Low-grade dysplasia in Barrett's esophagus: overdiagnosed and underestimated.

Authors:  Wouter L Curvers; Fiebo J ten Kate; Kausilia K Krishnadath; Mike Visser; Brenda Elzer; Lubertus C Baak; Clarisse Bohmer; Rosalie C Mallant-Hent; Arnout van Oijen; Anton H Naber; Pieter Scholten; Olivier R Busch; Harriët G T Blaauwgeers; Gerrit A Meijer; Jacques J G H M Bergman
Journal:  Am J Gastroenterol       Date:  2010-05-11       Impact factor: 10.864

5.  Dysplasia as a predictive marker for invasive carcinoma in Barrett esophagus: a follow-up study based on 138 cases from a diagnostic variability study.

Authors:  E Montgomery; J R Goldblum; J K Greenson; M M Haber; L W Lamps; G Y Lauwers; A J Lazenby; D N Lewin; M E Robert; K Washington; M L Zahurak; J Hart
Journal:  Hum Pathol       Date:  2001-04       Impact factor: 3.466

6.  A Barrett's esophagus registry of over 1000 patients from a specialist center highlights greater risk of progression than population-based registries and high risk of low grade dysplasia.

Authors:  S L Picardo; M P O'Brien; R Feighery; D O'Toole; N Ravi; N J O'Farrell; J N O'Sullivan; J V Reynolds
Journal:  Dis Esophagus       Date:  2014-01-15       Impact factor: 3.429

7.  Barrett's oesophagus patients with low-grade dysplasia can be accurately risk-stratified after histological review by an expert pathology panel.

Authors:  Lucas C Duits; K Nadine Phoa; Wouter L Curvers; Fiebo J W Ten Kate; Gerrit A Meijer; Cees A Seldenrijk; G Johan Offerhaus; Mike Visser; Sybren L Meijer; Kausilia K Krishnadath; Jan G P Tijssen; Rosalie C Mallant-Hent; Jacques J G H M Bergman
Journal:  Gut       Date:  2014-07-17       Impact factor: 23.059

8.  Risk stratification of patients with barrett's esophagus and low-grade dysplasia or indefinite for dysplasia.

Authors:  Prashanthi N Thota; Hyun-Ju Lee; John R Goldblum; Xiuli Liu; Madhusudhan R Sanaka; Tushar Gohel; Mehulkumar Kanadiya; Rocio Lopez
Journal:  Clin Gastroenterol Hepatol       Date:  2014-08-04       Impact factor: 11.382
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.